Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

EMJ GOLD: Pharma news, views and analysis

S03E03: Medical affairs, commercial and enhancing soft skills

20 Sep 2022

Description

This week’s episode features a fascinating conversation with Samin Saeed, UK Chief Scientific Officer and Medical Director at Novartis UK. She discusses a whole host of medical affairs-related issues, including the transition from medicine to pharma, cross-functionality, commercial versus medical affairs, and lots more besides, including a fascinating discussion about leadership, company culture and soft skills development. And ‘news you might have missed’ focuses on the European life sciences gender pay gap and new investment for Novartis.   If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: Preparing MSLs for the spotlight https://www.emg-gold.com/post/preparing-msls-for-the-spotlight Juby Jacob-Nara on medical affairs https://www.emg-gold.com/post/juby-jacob-nara-on-medical-affairs Aliya Omer on gender equality https://www.emg-gold.com/post/podcast-aliya-omer-on-gender-equality Reframing pharma’s bad boy reputation https://www.emg-gold.com/post/reframing-pharma-s-bad-boy-reputation Elevating pharma’s parental leave policies https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.